| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CELL.2009.04.040 |
| P698 | PubMed publication ID | 19410551 |
| P2093 | author name string | George A Calin | |
| Milena S Nicoloso | |||
| Carlo M Croce | |||
| Riccardo Spizzo | |||
| P433 | issue | 3 | |
| P304 | page(s) | 586-586.e1 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | SnapShot: MicroRNAs in Cancer | |
| P478 | volume | 137 |
| Q38637596 | A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease |
| Q24303520 | A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q35582977 | A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites |
| Q39201098 | Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma. |
| Q37597723 | Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes. |
| Q33575211 | Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood |
| Q34432844 | Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types |
| Q34315303 | BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia |
| Q37138668 | CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer |
| Q34924273 | Characterization of microRNA expression profiles and the discovery of novel microRNAs involved in cancer during human embryonic development |
| Q37450534 | Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes |
| Q91895987 | Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis |
| Q41688309 | Coarse-grained model for simulation of RNA three-dimensional structures. |
| Q34284145 | Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival |
| Q33647622 | Common genetic variants in the microRNA biogenesis pathway are not associated with breast cancer risk in Asian women |
| Q33962806 | Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. |
| Q34430590 | CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer |
| Q35861706 | Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma |
| Q35680893 | Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion |
| Q38988230 | Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis |
| Q91987616 | Determining expression of miRNAs that potentially regulate STAT5A and 5B in dasatinib-sensitive K562 cells |
| Q22000752 | Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development |
| Q64279874 | Enhanced expression of ten-eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P-glycoprotein expression |
| Q86589279 | Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer |
| Q51058502 | Expression Levels of Warburg-Effect Related microRNAs Correlate with each Other and that of Histone Deacetylase Enzymes in Adult Hematological Malignancies with Emphasis on Acute Myeloid Leukemia. |
| Q38980837 | Expression patterns of miR-221 and its target Caspase-3 in different cancer cell lines. |
| Q30493496 | Extracting consistent knowledge from highly inconsistent cancer gene data sources |
| Q37361507 | Fractal-like kinetics of intracellular enzymatic reactions: a chemical framework of endotoxin tolerance and a possible non-specific contribution of macromolecular crowding to cross-tolerance |
| Q57284007 | Framework for microRNA variant annotation and prioritization using human population and disease datasets |
| Q34043449 | From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies |
| Q34334088 | Genetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality? |
| Q37309427 | Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population |
| Q37225586 | Genetic variants in lncRNA SRA and risk of breast cancer |
| Q36413501 | Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma |
| Q28272905 | Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update |
| Q33711948 | Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets |
| Q42949265 | Identification of microRNA activity by Targets' Reverse EXpression |
| Q38888869 | Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile |
| Q35742497 | Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells. |
| Q39246325 | Long non-coding RNAs in cutaneous melanoma: clinical perspectives. |
| Q28283392 | MYC-microRNA-9-metastasis connection in breast cancer |
| Q34822660 | MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1 |
| Q36286673 | MiR-320e is a novel prognostic biomarker in colorectal cancer. |
| Q47716490 | MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification. |
| Q60956729 | MiRNA Polymorphisms and Cancer Prognosis: A Systematic Review and Meta-Analysis |
| Q37062650 | MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. |
| Q38493279 | MicroRNA and MET in lung cancer |
| Q37833066 | MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk |
| Q37683051 | MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. |
| Q31080906 | MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing |
| Q55419057 | MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway. |
| Q89619891 | MicroRNA-141-5p Acts as a Tumor Suppressor via Targeting RAB32 in Chronic Myeloid Leukemia |
| Q41558190 | MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer |
| Q90403264 | MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations |
| Q52671332 | MicroRNA-331 inhibits proliferation and invasion of melanoma cells by targeting astrocyte-elevated gene-1. |
| Q34894800 | MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells |
| Q35550210 | MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A |
| Q33786861 | MicroRNA: important player in the pathobiology of multiple myeloma |
| Q35704188 | MicroRNAome genome: a treasure for cancer diagnosis and therapy. |
| Q35994443 | MicroRNAs and other non-coding RNAs as targets for anticancer drug development |
| Q34585272 | MicroRNAs as biomarkers in rheumatic diseases. |
| Q26775610 | MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer |
| Q26824682 | MicroRNAs in B-cells: from normal differentiation to treatment of malignancies |
| Q38258754 | MicroRNAs in cancer therapeutic response: Friend and foe |
| Q38035144 | MicroRNAs in the p53 network: micromanagement of tumour suppression |
| Q33942272 | MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. |
| Q42315390 | Microscale Symmetrical Electroporator Array as a Versatile Molecular Delivery System |
| Q28729012 | Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer |
| Q34293710 | Molecular dynamics simulations of Ago silencing complexes reveal a large repertoire of admissible 'seed-less' targets. |
| Q27004373 | Molecular pathways: microRNAs, cancer cells, and microenvironment |
| Q24596715 | NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes |
| Q53228628 | Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. |
| Q33762263 | Non-coding RNAs: a key to future personalized molecular therapy? |
| Q34402678 | Novel insights of structure-based modeling for RNA-targeted drug discovery |
| Q44043709 | OMiR: Identification of associations between OMIM diseases and microRNAs |
| Q38940602 | Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer |
| Q43010589 | Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis |
| Q58122193 | Prediction of Potential Small Molecule-Associated MicroRNAs Using Graphlet Interaction |
| Q33579255 | Principles of microRNA involvement in human cancers |
| Q38715962 | Prognostic role of circulating exosomal miRNAs in multiple myeloma |
| Q51642483 | Ranking of microRNA target prediction scores by Pareto front analysis |
| Q35206650 | Recent advances in colorectal cancer research: the microenvironment impact |
| Q54957988 | Reduced miR-433 expression is associated with advanced stages and early relapse of colorectal cancer and restored miR-433 expression suppresses the migration, invasion and proliferation of tumor cells in vitro and in nude mice. |
| Q27026972 | Regulating miRNA by natural agents as a new strategy for cancer treatment |
| Q51103234 | Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. |
| Q33812540 | Reprogramming of miRNA networks in cancer and leukemia |
| Q35025776 | Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: functional and mechanistic implications |
| Q36844904 | Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience |
| Q34087933 | SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells. |
| Q33782791 | Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility |
| Q26829982 | Small molecule compounds targeting miRNAs for cancer therapy |
| Q33835075 | Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing |
| Q34246676 | Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells |
| Q27008867 | Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review |
| Q37826351 | The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade |
| Q92280511 | The Roles of miRNAs in Medulloblastoma: A Systematic Review |
| Q34220723 | The clinical potential of microRNAs |
| Q36603037 | The mix of two worlds: non-coding RNAs and hormones |
| Q37912078 | The therapeutic potential of microRNAs: disease modulators and drug targets. |
| Q24651333 | Therapeutic microRNA strategies in human cancer |
| Q89292028 | Using microRNA Networks to Understand Cancer |
| Q52780004 | bantam miRNA is important for Drosophila blood cell homeostasis and a regulator of proliferation in the hematopoietic progenitor niche. |
| Q38644655 | miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway. |
| Q34292411 | miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells |
| Q64084728 | miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling |
| Q34013539 | miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase |
| Q39674586 | miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. |
| Q38764745 | miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia |
| Q43144202 | miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1. |
| Q37529983 | miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration |
| Q27025496 | miRNA Deregulation in Cancer Cells and the Tumor Microenvironment |
| Q28078451 | miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers |
| Q36456399 | microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs |
Search more.